Literature DB >> 25652328

Preventing and managing herpes zoster: key actions to foster healthy aging.

Stefania Maggi1, Giovanni Gabutti, Elisabetta Franco, Paolo Bonanni, Michele Conversano, Antonio Ferro, Marzia Lazzari, Alessandro Rossi, Silvestro Scotti, Francesco Vitale, Antonio Volpi, Donato Greco.   

Abstract

Population aging is the demographic phenomenon characterizing all countries in the world, and it is challenging the national infrastructures, in particular health systems. However, aging itself is not associated with increased medical spending, but disability and comorbidity that affect older individuals are the actual drivers for health expenditures. Therefore, if people age in better health, medical spending may be significantly reduced. Preventative interventions proved to be effective in reducing/preventing disease and disability and often found to be cost effective, include diet and exercise interventions, medications, routine disease screenings, and immunizations. Vaccination can protect older citizens against life-threatening diseases, such as influenza, pneumococcal infections, tetanus, and against diseases which adversely impact their quality of life, such as herpes zoster (HZ). Including HZ vaccination in its citizens' lifetime immunization calendar can reinforce Europe's commitment toward active, healthy aging. This paper outlines the consensus statement of a group of Italian experts on HZ.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25652328     DOI: 10.1007/s40520-015-0314-7

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  4 in total

1.  Impact of Underlying Conditions on Zoster-Related Pain and on Quality of Life Following Zoster.

Authors:  Laurence Torcel-Pagnon; Hélène Bricout; Isabelle Bertrand; Emilia Perinetti; Elisabetta Franco; Giovanni Gabutti; Antonio Volpi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-08-01       Impact factor: 6.053

Review 2.  A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile.

Authors:  Federica Brosio; Giulia Masetti; Giulio Matteo; Armando Stefanati; Giovanni Gabutti
Journal:  Infect Drug Resist       Date:  2018-09-05       Impact factor: 4.003

Review 3.  Real-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive Review.

Authors:  Filippo Ansaldi; Cecilia Trucchi; Cristiano Alicino; Chiara Paganino; Andrea Orsi; Giancarlo Icardi
Journal:  Adv Ther       Date:  2016-06-04       Impact factor: 3.845

4.  Risk and impact of herpes zoster among COPD patients: a population-based study, 2009-2014.

Authors:  Cintia Muñoz-Quiles; Mónica López-Lacort; Javier Díez-Domingo
Journal:  BMC Infect Dis       Date:  2018-05-03       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.